ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Foreign firms invest in research in New Jersey

by Michael McCoy
August 13, 2020 | APPEARED IN VOLUME 98, ISSUE 31

Two overseas firms are investing in New Jersey as their main US research hubs. The Japanese company Eisai will move its US headquarters and R&D facility, which employs about 1,200 people, from Woodcliff Lake, New Jersey, to the former Roche research campus in Nutley. Roche made waves in 2012 when it announced the closure of the Nutley research site, eliminating 1,000 jobs and accelerating big pharma’s departure from the state. Since then, other companies and institutions, including Quest Diagnostics and Seton Hall University’s medical and nursing schools, have moved into the site, now called ON3. With Eisai’s move, the owners say the site will be at 100% capacity. Separately, the British specialty chemical maker Croda has begun building a North American headquarters and innovation center near Princeton to replace its current quarters in Edison, New Jersey. The project will feature 1,000 m2 of laboratory space and a 275 m2 “customer experience” center, Croda says.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment